{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:35:03Z","timestamp":1785900903992,"version":"3.56.0"},"reference-count":56,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T00:00:00Z","timestamp":1299024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Studies utilizing selective pharmacological antagonists or targeted gene deletion have demonstrated thattype 5 metabotropic glutamate receptors (mGluR5) are critical mediators and potential therapeutic targets for the treatment of numerous disorders of the central nervous system (CNS), including depression, anxiety, drug addiction, chronic pain, Fragile X syndrome, Parkinson\u2019s disease, and gastroesophageal reflux disease. However, in recent years, the development of positive allosteric modulators (PAMs) of the mGluR5 receptor have revealed that allosteric activation of this receptor may also be of potential therapeutic benefit for the treatment of other CNS disorders, including schizophrenia, cognitive deficits associated with chronic drug use, and deficits in extinction learning. Here we summarize the discovery and characterization of various mGluR5 PAMs, with an emphasis on those that are systemically active. We will also review animal studies showing that these molecules have potential efficacy as novel antipsychotic agents. Finally, we will summarize findings that suggest that mGluR5 PAMs have pro-cognitive effects such as the ability toenhance synaptic plasticity, improve performance in various learning and memory tasks, including extinction of drug-seeking behavior, and reverse cognitive deficits produced by chronic drug use.<\/jats:p>","DOI":"10.3390\/molecules16032097","type":"journal-article","created":{"date-parts":[[2011,3,3]],"date-time":"2011-03-03T23:15:03Z","timestamp":1299194103000},"page":"2097-2106","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Positive Allosteric Modulators of Type 5 Metabotropic Glutamate Receptors (mGluR5) and Their Therapeutic Potential for the Treatment of CNS Disorders"],"prefix":"10.3390","volume":"16","author":[{"given":"Richard M.","family":"Cleva","sequence":"first","affiliation":[{"name":"Department of Psychology, Arizona State University, Tempe, Arizona 85287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Foster","family":"Olive","sequence":"additional","affiliation":[{"name":"Department of Psychology, Arizona State University, Tempe, Arizona 85287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2011,3,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/1073858402238514","article-title":"Metabotropic glutamate receptors: Electrical and chemical signaling properties","volume":"8","author":"Coutinho","year":"2002","journal-title":"Neuroscientist"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/bj3590465","article-title":"Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: Prototypic family C G-protein-coupled receptors","volume":"359","author":"Hermans","year":"2001","journal-title":"Biochem. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pharmthera.2005.01.008","article-title":"Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis","volume":"111","author":"Dhami","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: Physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13361","DOI":"10.1016\/S0021-9258(18)42219-3","article-title":"Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate\/Ca2+ signal transduction","volume":"267","author":"Abe","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(93)90227-C","article-title":"Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain","volume":"163","author":"Shigemoto","year":"1993","journal-title":"Neurosci. Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cne.903550310","article-title":"Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain","volume":"355","author":"Romano","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.02.041","article-title":"Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain","volume":"1149","author":"Mudo","year":"2007","journal-title":"Brain Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1046\/j.1460-9568.2003.02657.x","article-title":"Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: Opposite regulation of glutamate transporter proteins","volume":"17","author":"Aronica","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<533::AID-JNR6>3.0.CO;2-G","article-title":"mGluR3 and mGluR5 are the predominant metabotropic glutamate receptor mRNAs expressed in hippocampal astrocytes acutely isolated from young rats","volume":"58","author":"Schools","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1074\/jbc.M705661200","article-title":"Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors","volume":"283","author":"Perroy","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bjp.0703904","article-title":"Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges","volume":"132","author":"Attucci","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","article-title":"Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus","volume":"20","author":"Awad","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0028-3908(97)00001-4","article-title":"(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but not mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus","volume":"36","author":"Doherty","year":"1997","journal-title":"Neuropharmacology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(01)00297-4","article-title":"Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons","volume":"106","author":"Pisani","year":"2001","journal-title":"Neuroscience"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0028-3908(99)00095-7","article-title":"Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons","volume":"38","author":"Ugolini","year":"1999","journal-title":"Neuropharmacology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2010.02.057","article-title":"Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator","volume":"639","author":"Rosenbrock","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1358\/dof.2008.033.04.1186966","article-title":"mGluR5 positive allosteric modulators","volume":"33","author":"Chen","year":"2008","journal-title":"Drugs Fut."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2760","article-title":"Allosteric modulators of GPCRs: A novel approach for the treatment of CNS disorders","volume":"8","author":"Conn","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tips.2008.10.006","article-title":"Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia","volume":"30","author":"Conn","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuropharm.2010.07.007","article-title":"Allosteric modulation of metabotropic glutamate receptors: Structural insights and therapeutic potential","volume":"60","author":"Gregory","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/11533230-000000000-00000","article-title":"Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists","volume":"24","author":"Krystal","year":"2010","journal-title":"CNS Drugs"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1742-7843.2005.pto_156.x","article-title":"Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators","volume":"97","author":"Ritzen","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/npp.2009.30","article-title":"mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning","volume":"34","author":"Ayala","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuroscience.2006.06.043","article-title":"Allosteric enhancement of metabotropic glutamate receptor 5 function promotes spatial memory","volume":"142","author":"Balschun","year":"2006","journal-title":"Neuroscience"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuropharm.2009.07.022","article-title":"Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus","volume":"57","author":"Uslaner","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1037\/a0022339","article-title":"mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration","volume":"125","author":"Cleva","year":"2011","journal-title":"Behav. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2010.01.028","article-title":"Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade","volume":"639","author":"Stefani","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pbb.2010.01.010","article-title":"MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: Relevance to negative symptoms associated with schizophrenia?","volume":"95","author":"Vardigan","year":"2010","journal-title":"Pharmaco. Biochem. Behav."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FBP.0b013e3282feb0ac","article-title":"Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm","volume":"19","author":"Darrah","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568007023339544","article-title":"Direct and indirect modulation of the N-methyl D-aspartate receptor: Potential for the development of novel antipsychotic therapies","volume":"1","author":"Marino","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coph.2005.09.006","article-title":"Glutamate-based therapeutic approaches: Allosteric modulators of metabotropic glutamate receptors","volume":"6","author":"Marino","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/mi.8.2.7","article-title":"Schizophrenia: Moving beyond monoamine antagonists","volume":"8","author":"Conn","year":"2008","journal-title":"Mol. Interv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1124\/mol.64.3.731","article-title":"A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5","volume":"64","author":"Lemaire","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.103.061747","article-title":"A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 (mGluR5) in rat forebrain","volume":"309","author":"Lemaire","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1021\/jm049400d","article-title":"Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides that potentiate receptor function in vivo","volume":"47","author":"Lindsley","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/jpet.104.079244","article-title":"A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models","volume":"313","author":"Kinney","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.108.136580","article-title":"ADX47273: A novel metabotropic glutamate receptor 5 selective positive allosteric modulator with preclinical antipsychotic-like and pro-cognitive activities","volume":"327","author":"Liu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1124\/mol.106.032425","article-title":"Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses","volume":"71","author":"Chen","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/cmdc.200800357","article-title":"Synthesis, SAR and unanticipated pharmacological profiles of analogues of the mGluR5 ago-potentiator ADX-47273","volume":"4","author":"Engers","year":"2009","journal-title":"ChemMedChem"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1021\/jm900654c","article-title":"Discovery of molecular switches that modulate modes of metabotropic glutamate receptor subtype 5 (mGlu5) pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidines","volume":"52","author":"Sharma","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1124\/mol.110.067207","article-title":"Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity","volume":"78","author":"Rodriguez","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1124\/mol.105.016139","article-title":"A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators","volume":"68","author":"Rodriguez","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1124\/mol.107.040097","article-title":"N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hy droxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors","volume":"73","author":"Chen","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/jpet.105.090308","article-title":"Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes","volume":"315","author":"Zhang","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/cn100051m","article-title":"Discovery of a novel chemical class of mGlu5 allosteric ligands with distinct modes of pharmacology","volume":"1","author":"Hammond","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Parmentier-Batteur, S., Obrien, J.A., Doran, S., Nguyen, S.J., Flick, R.B., Uslaner, J.M., Chen, H., Finger, E.N., Williams, T.M., Jacobson, M.A., and Hutson, P.H. (2011). Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration. Neuropharmacology, in press.","DOI":"10.1016\/j.neuropharm.2010.11.013"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nlm.2010.11.009","article-title":"Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats","volume":"95","author":"Fowler","year":"2011","journal-title":"Neurobiol. Learn Mem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"18041","DOI":"10.1073\/pnas.0806669105","article-title":"Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs","volume":"105","author":"Homayoun","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2009.12.042","article-title":"Group 5 metabotropic glutamate receptors: Role in modulating cortical activity and relevance to cognition","volume":"639","author":"Homayoun","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.biopsych.2006.12.003","article-title":"Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex","volume":"62","author":"Lecourtier","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1874473710902010083","article-title":"Metabotropic glutamate receptor ligands as potential therapeutics for drug addiction","volume":"2","author":"Olive","year":"2009","journal-title":"Curr. Drug Abuse Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2010.01.029","article-title":"Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction","volume":"639","author":"Olive","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.biopsych.2008.11.001","article-title":"Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory","volume":"65","author":"Gass","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/npp.2010.212","article-title":"Loss of object recognition memory produced by exteded access to methamphetamine self-admistration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5","volume":"36","author":"Reichel","year":"2011","journal-title":"Neuropsychopharmacology"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/16\/3\/2097\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:55:25Z","timestamp":1760219725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/16\/3\/2097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,2]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3]]}},"alternative-id":["molecules16032097"],"URL":"https:\/\/doi.org\/10.3390\/molecules16032097","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,2]]}}}